Loading
Latest filing published 14 Jan 2008 for VioQuest Pharmaceuticals, Inc., €336.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Michael D. Becker span 2 companies, the busiest being Cytogen Corp and VioQuest Pharmaceuticals, Inc. The record holds 7 filings, for trades running from 4 April 2006 to 14 January 2008.
The open-market record is one-sided, with 3 purchases worth €3,420 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants. So far in 2008, the count stands at 3 purchases and no sales.
The median purchase comes to €706.
The newest entry dates from 14 January 2008: an open-market purchase of €336, in VioQuest Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations